Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01) Download the PDF here. This post appeared first on investingnews.com 0 Related Posts Newmont to Delist from Toronto Stock Exchange as Cost Cuts Deepen September 15, 2025 Completion of Non-Renounceable Pro-Rata Entitlement Offer September 15, 2025 Significant Enlargement of Exploration Program September 15, 2025